Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
356 Results for "
Cap
" in MedChemExpress (MCE) Product Catalog:
Products (356)
356 Results for "Cap" in MCE Product Catalog:
Cat. No.: HY-P70152
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: EIF4E; EIF-4F 25 KDa Subunit; Prev. EIF4EL1; Eukaryotic Translation Initiation Factor 4E-Like 1; Prev. EIF4F; AUTS19; EIF4E1; CBP; MRNA Cap-Binding Protein; Eukaryotic Translation Initiation Factor 4E; EIF-4E
Species:
Human
Source:
E. coli
Cat. No.: HY-P70886
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: NDRG1; Protein NDRG1; Prev. Cap43; Protein Regulated By Oxygen-1; DRG1; PROXY1; RTP; CMT4D; TDD5; HMSNL; NDR1; RIT42; Reducing Agents And Tunicamycin-Responsive Protein; TARG1; N-Myc Downstream-Regulated Gene 1 Protein; Rit42; Nickel-Specific Induction Pr
Species:
Human
Source:
E. coli
Cat. No.: HY-P71708
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CASP8; Apoptotic Cysteine Protease; Caspase 8; Apoptotic Protease Mch-5; FLICE; FADD-Like ICE; MCH5; Cap4; MACH; FADD-Homologous ICE/CED-3-Like Protease; Caspase-8; FADD-Homologous ICE/Ced-3-Like Protease; Casp-8; MACH-Beta-1/2/3/4 Protein; Caspase 8, Apo
Species:
Human
Source:
E. coli
Cat. No.: HY-P700570
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDKN1A; Cdk-Interacting Protein 1; Prev. CDKN1; MDA-6; Cap20; Melanoma Differentiation Associated Protein 6; CIP1; Melanoma Differentiation-Associated Protein 6; WAF1; Wild-Type P53-Activated Fragment 1; SDI1; CDK-Interaction Protein 1; P21; CDK-Interacti
Species:
Human
Source:
E. coli
Cat. No.: HY-P703422
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: EIF4E; EIF-4F 25 KDa Subunit; Prev. EIF4EL1; Eukaryotic Translation Initiation Factor 4E-Like 1; Prev. EIF4F; AUTS19; EIF4E1; CBP; MRNA Cap-Binding Protein; Eukaryotic Translation Initiation Factor 4E; EIF-4E
Species:
Human
Source:
E. coli
Cat. No.: HY-P790103
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TRAF3; CD40 Receptor-Associated Factor 1; TNF Receptor Associated Factor 3; TNF Receptor-Associated Factor; CRAF1; CD40 Associated Protein 1; Cap-1; CD40 Binding Protein; LAP1; CD40-Binding Protein; RNF118; IMD132B; CD40bp; IMD132A; RING-Type E3 Ubiquitin
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P86979
Synonyms: 2810406C15Rik antibody; 2810465G24Rik antibody; Cap-D2 antibody; CapD2 antibody; CEP2 antibody; CEP250 antibody; Chromosome condensation-related SMC-associated protein 1 antibody; Chromosome-associated protein D2 antibody; CNAP1 antibody; CND1 antibody; 2810406C15Rik antibody; 2810465G24Rik antibody; Cap-D2 antibody; CapD2 antibody; CEP2 antibody; CEP250 antibody; Chromosome condensation-related SMC-associated protein 1 antibody; Chromosome-associated protein D2 antibody; CNAP1 antibody; CND1 antibody; Condensin antibody; Condensin complex subunit 1 antibody; eg7 antibody; hCap-D2 antibody; hCapD2 antibody; KIAA0159 antibody; mKIAA0159 antibody; NCapD2 antibody; non-SMC condensin I complex, subunit D2 antibody; XCap D2 homolog antibody;
Cat. No.: HY-P81161
Synonyms: Apoptotic cysteine protease; Apoptotic protease Mch 5; C/EBP alpha; Cap4; Caspase 8 precursor; CCAAT Enhancer Binding Protein alpha; CEBP; CEBP A; CEBP alpha; CEBPA; FADD homologous ICE/CED 3 like protease; FADD like ICE; FLICE; ICE like apoptotic protease 5; ICE8; MACH; MCH5; MORT1 associated CED 3 homolog; CEBP α, CEBP-α.
Cat. No.: HY-170524
CAS No.: 3052313-73-9
Research Areas:
TDI-015051 is a highly selective, orally active antiviral agent that targets the coronavirus NSP14 guanine-N7 methyltransferase. TDI-015051 binds to substrates in a non-competitive manner and forms a stable ternary complex, precisely blocking the capping and methylation processes of viral mRNA. TDI-015051 potently inhibits a variety of coronaviruses (including SARS-CoV-2 and MERS). By impairing viral replication and translation and inducing a moderate type I interferon-mediated immune response, it significantly reduces pulmonary viral load and exhibits a synergistic effect with Nirmatrelvir (HY-138687). In addition, TDI-015051 does not inhibit non-coronavirus methyltransferases, and the drug-resistant mutations it induces impair viral fitness, demonstrating excellent antiviral properties and safety. TDI-015051 can be used for research on COVID-19 and the replication mechanism of coronaviruses .The IC50 values of TDI-015051 against SARS-CoV-2, α-hCoV-NL63, α-hCoV-229E, β-hCoV-MERS are 0.15 nM, 1.7 nM, 2.6 nM and 3.6 nM, respectively, and the Ka value against SARS-CoV-2 is 0.061 nM .
Cat. No.: HY-P87076
Synonyms: Cap E antibody; CapE antibody; Chromosome associated protein E antibody; Chromosome-associated protein E antibody; FLJ10093 antibody; hCap E antibody; hCap-E antibody; hCapE antibody; PRO0324 antibody; SMC 2 antibody; Cap E antibody; CapE antibody; Chromosome associated protein E antibody; Chromosome-associated protein E antibody; FLJ10093 antibody; hCap E antibody; hCap-E antibody; hCapE antibody; PRO0324 antibody; SMC 2 antibody; SMC protein 2 antibody; SMC-2 antibody; SMC2 antibody; SMC2 L1 antibody; SMC2_HUMAN antibody; SMC2L1 antibody; Structural maintenance of chromosomes (SMC) family member chromosome associated protein E antibody; Structural maintenance of chromosomes 2 antibody; Structural maintenance of chromosomes 2 like 1 antibody; Structural maintenance of chromosomes 2 yeast like 1 antibody; Structural maintenance of chromosomes protein 2 antibody; XCap E homolog antibody; XCap-E homolog antibody; XCapE homolog antibody;
Cat. No.: HY-189094
Target:
Research Areas:
DcpS-IN-1 is an orally active DcpS inhibitor with an IC50 of 0.16 nM against hDcpS. DcpS-IN-1 exhibits anticancer activity against lung squamous cell carcinoma and head and neck squamous cell carcinoma. DcpS-IN-1 can be used in the research of solid tumors .
Cat. No.: HY-P87164
Synonyms: Cap20 antibody; CDK-interacting protein 1 antibody; CDKI antibody; CDKN1 antibody; Cdkn1a antibody; CDN1A_HUMAN antibody; CIP1 antibody; Cyclin Dependent Kinase Inhibitor 1A antibody; Cyclin-dependent kinase inhibitor 1 antibody; Cyclin-dependent kinase inhibitor 1A (P21) antibody; Cap20 antibody; CDK-interacting protein 1 antibody; CDKI antibody; CDKN1 antibody; Cdkn1a antibody; CDN1A_HUMAN antibody; CIP1 antibody; Cyclin Dependent Kinase Inhibitor 1A antibody; Cyclin-dependent kinase inhibitor 1 antibody; Cyclin-dependent kinase inhibitor 1A (P21) antibody; Cyclin-dependent kinase inhibitor 1A (p21, Cip1) antibody; DNA Synthesis Inhibitor antibody; MDA-6 antibody; MDA6 antibody; Melanoma differentiation-associated protein 6 antibody; Melanoma differentiation-associated protein antibody; p21 antibody; P21 protein antibody; p21CIP1 antibody; p21Cip1/Waf1 antibody; p21WAF antibody; PIC1 antibody; SDI1 antibody; SLC12A9 antibody; WAF1 antibody; Wild type p53 activated fragment 1 (WAF1) antibody; Wild type p53 activated fragment 1 antibody; Wildtype p53-activated fragment 1 antibody;
Cat. No.: HY-P85604
Synonyms: ATP dependent RNA helicase DDX3X; ATP-dependent RNA helicase DDX3X; Cap Rf; DBX; DDX14; DDX3X; DDX3X_HUMAN; DEAD; Asp Glu Ala Asp; box polypeptide 3 X linked; DEAD box; DEAD box protein 3; DEAD box protein 3 X-chromosomal; DEAD box X isoform; DEAD/H; Asp Glu Ala Asp/His; box polypeptide 3; DEAD/H box 3; DEAD/H box 3, X-linked; Fibroblast Growth Factor Inducible 14; Fin14; Helicase like protein 2; Helicase-like protein 2; HLP2; X isoform; X-chromosomal.
Cat. No.: HY-P704778
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ST14; Matriptase; Prev. PRSS14; TADG15; MT-SP1; Suppression Of Tumorigenicity 14 (Colon Carcinoma, Matriptase, Epithin); SNC19; Tumor Associated Differentially Expressed Gene 15 Protein; TMPRSS14; Tumor-Associated Differentially-Expressed Gene 15 Protein; Cap3; Suppression Of Tumorigenicity 14; HAI; Channel–Activating Protein 3; Suppression Of Tumorigenicity 14 (Colon Carcinoma); Channel-Activating Protein 3; Suppressor Of Tumorigenicity 14 Protein; ST14 Protein; Membrane-Type Serine Protease 1; Epithin; Serine Protease TADG-15; ARCI11; Serine Protease 14; MTSP1; ST14 Transmembrane Serine Protease Matriptase; Prostamin
Species:
Human
Source:
E. coli
Cat. No.: HY-P701371
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDK7; Cyclin-Dependent Kinase 7 (Homolog Of Xenopus MO15 Cdk-Activating Kinase); Cyclin Dependent Kinase 7; Homolog Of Xenopus MO15 Cdk-Activating Kinase; CDKN7; Serine/Threonine Protein Kinase MO15; CAK1; Cyclin-Dependent Kinase 7 Isoform 3; MO15; Serine/Threonine Protein Kinase 1; STK1; Serine/Threonine-Protein Kinase 1; CAK; [RNA-Polymerase]-Subunit Kinase; TFIIH Basal Transcription Factor Complex Kinase Subunit; Serine/Threonine Kinase Stk1; Cell Division Protein Kinase 7; Kinase Subunit Of CAK; Cyclin-Dependent Kinase 7; P39 Mo15; Cyclin-Dependent Kinase 7 (MO15 Homolog, Xenopus Laevis, Cdk-Activating Kinase); P39MO15; CDK-Activating Kinase 1; HCAK; 39 KDa Protein Kinase; CCNH; CycH; Cyclin H; Cyclin-Dependent Kinase-Activating Kinase Complex Subunit; P34; CDK-Activating Kinase Complex Subunit; P37; CAK Complex Subunit; MO15-Associated Protein; CAK; Cyclin-H; MNAT1; Cap35; MNAT1 Component Of CDK Activating Kinase; P36; RNF66; P35; MAT1; Menage A Trois Homolog 1, Cyclin H Assembly Factor (Xenopus Laevis); CDK-Activating Kinase Assembly Factor MAT1; Menage A Trois-Like Protein 1 Cyclin H Assembly Factor Isoform 2; CDK7/Cyclin-H Assembly Factor; Menage A Trois-Like Protein 1 Cyclin H Assembly Factor; RING Finger Protein MAT1; Menage A Trois Homolog 1, Cyclin H Assembly Factor; MNAT CDK-Activating Kinase Assembly Factor 1; CDK-Activating Kinase Assembly Factor; MNAT1, CDK Activating Kinase Assembly Factor; Cyclin G1 Interacting Protein; Menage A Trois 1 (CAK Assembly Factor); Cyclin-G1-Interacting Protein; RING Finger Protein 66; TFB3; Menage A Trois
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P75361
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK7; Cyclin-Dependent Kinase 7 (Homolog Of Xenopus MO15 Cdk-Activating Kinase); Cyclin Dependent Kinase 7; Homolog Of Xenopus MO15 Cdk-Activating Kinase; CDKN7; Serine/Threonine Protein Kinase MO15; CAK1; Cyclin-Dependent Kinase 7 Isoform 3; MO15; Serine/Threonine Protein Kinase 1; STK1; Serine/Threonine-Protein Kinase 1; CAK; [RNA-Polymerase]-Subunit Kinase; TFIIH Basal Transcription Factor Complex Kinase Subunit; Serine/Threonine Kinase Stk1; Cell Division Protein Kinase 7; Kinase Subunit Of CAK; Cyclin-Dependent Kinase 7; P39 Mo15; Cyclin-Dependent Kinase 7 (MO15 Homolog, Xenopus Laevis, Cdk-Activating Kinase); P39MO15; CDK-Activating Kinase 1; HCAK; 39 KDa Protein Kinase; CCNH; CycH; Cyclin H; Cyclin-Dependent Kinase-Activating Kinase Complex Subunit; P34; CDK-Activating Kinase Complex Subunit; P37; CAK Complex Subunit; MO15-Associated Protein; CAK; Cyclin-H; MNAT1; Cap35; MNAT1 Component Of CDK Activating Kinase; P36; RNF66; P35; MAT1; Menage A Trois Homolog 1, Cyclin H Assembly Factor (Xenopus Laevis); CDK-Activating Kinase Assembly Factor MAT1; Menage A Trois-Like Protein 1 Cyclin H Assembly Factor Isoform 2; CDK7/Cyclin-H Assembly Factor; Menage A Trois-Like Protein 1 Cyclin H Assembly Factor; RING Finger Protein MAT1; Menage A Trois Homolog 1, Cyclin H Assembly Factor; MNAT CDK-Activating Kinase Assembly Factor 1; CDK-Activating Kinase Assembly Factor; MNAT1, CDK Activating Kinase Assembly Factor; Cyclin G1 Interacting Protein; Menage A Trois 1 (CAK Assembly Factor); Cyclin-G1-Interacting Protein; RING Finger Protein 66; TFB3; Menage A Trois
Species:
Human
Source:
Sf9 insect cells
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
